1 rich Libsyn https://www.libsyn.com 90 600 Here we feature a central figure in the ongoing Great World Fluid debate. He was sadly unable to attend EBPOM 2018 so we wanted to get a very important contribution from him: What are the big takeaways from some of the larger trials such as Saline versus Albumin&amp;nbsp;Fluid&amp;nbsp;Evaluation (SAFE)? What about the long term implications of&amp;nbsp;Crystalloid versus Hydroxyethyl Starch Trial (CHEST)? What new trials should be on the horizon - given the information we now have? Monty Mythen&amp;nbsp;speaks with his guest&amp;nbsp;Professor&amp;nbsp;John A Myburgh, Intensive Care Medicine, University of New South Wales; Director of the Division of Critical Care and Trauma at the George Institute for Global Health and Senior Intensive Care Physician at the St George Hospital, Sydney. &amp;nbsp; He holds honorary Professorial appointments at the University of Sydney and Monash University School of Public Health and Preventive Medicine. TopMedTalk https://www.topmedtalk.com <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/10482794/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/3a5fa9/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/46916330